BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Geng F, Wang Z, Yin H, Yu J, Cao B. Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives. Cancer Biother Radiopharm 2017;32:149-60. [PMID: 28622036 DOI: 10.1089/cbr.2017.2210] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Echle A, Rindtorff NT, Brinker TJ, Luedde T, Pearson AT, Kather JN. Deep learning in cancer pathology: a new generation of clinical biomarkers. Br J Cancer 2021;124:686-96. [PMID: 33204028 DOI: 10.1038/s41416-020-01122-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
2 Liu Z, Chen C, Yan M, Zeng X, Zhang Y, Lai D. CENPO regulated proliferation and apoptosis of colorectal cancer in a p53-dependent manner. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00469-2] [Reference Citation Analysis]
3 Wang C, Yin W, Chen P. MicroRNA-374a-5p promotes metastasis of colorectal cancer by targeting GRB7. Panminerva Med 2021;63:555-7. [PMID: 31985182 DOI: 10.23736/S0031-0808.19.03789-3] [Reference Citation Analysis]
4 Bai C, Zhang Z, Zhou L, Zhang HY, Chen Y, Tang Y. Repurposing Ziyuglycoside II Against Colorectal Cancer via Orchestrating Apoptosis and Autophagy. Front Pharmacol 2020;11:576547. [PMID: 33071789 DOI: 10.3389/fphar.2020.576547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Pan R, Zhang Z, Jia H, Ma J, Wu C, Xue P, Cai W, Zhang X, Sun J. CAMTA1-PPP3CA-NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin. Cell Death Discov 2022;8:129. [PMID: 35332122 DOI: 10.1038/s41420-022-00912-x] [Reference Citation Analysis]
6 Babaei A, Soleimanjahi H, Soleimani M, Arefian E. The synergistic anticancer effects of ReoT3D, CPT-11, and BBI608 on murine colorectal cancer cells. Daru 2020;28:555-65. [PMID: 32803686 DOI: 10.1007/s40199-020-00361-w] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Huang S, Peng W, Mao D, Zhang S, Xu P, Yi P, Zhang S. Kangai Injection, a Traditional Chinese Medicine, Improves Efficacy and Reduces Toxicity of Chemotherapy in Advanced Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2019;2019:8423037. [PMID: 31379968 DOI: 10.1155/2019/8423037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
8 Li B, Liu X, Wu G, Liu J, Cai S, Wang F, Yang C, Liu J. MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2. Bioengineered 2021. [PMID: 34699325 DOI: 10.1080/21655979.2021.1996505] [Reference Citation Analysis]
9 Rutkowska A, Stoczyńska-Fidelus E, Janik K, Włodarczyk A, Rieske P. EGFRvIII: An Oncogene with Ambiguous Role. J Oncol 2019;2019:1092587. [PMID: 32089685 DOI: 10.1155/2019/1092587] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
10 Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557-588. [PMID: 32606456 DOI: 10.1038/s41575-020-0310-z] [Cited by in Crossref: 160] [Cited by in F6Publishing: 167] [Article Influence: 80.0] [Reference Citation Analysis]
11 Han YH, Kee JY, Hong SH. Rosmarinic Acid Activates AMPK to Inhibit Metastasis of Colorectal Cancer. Front Pharmacol 2018;9:68. [PMID: 29459827 DOI: 10.3389/fphar.2018.00068] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
12 Liang X, Shen J. Impact of KRAS mutation status on outcomes of metastatic colorectal cancer treated with anti-angiogenic agents: a meta-analysis. Journal of Chemotherapy 2020;32:41-8. [DOI: 10.1080/1120009x.2019.1692282] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Kim YJ, Cho AR, Sul HJ, Kim B, Kim AY, Kim HS, Seo JB, Koh Y, Zang DY. The effects of crizotinib in a transgenic Drosophila model expressing the human TPM4-ALK fusion gene or TPM4. Biol Open 2019;8:bio044362. [PMID: 31278140 DOI: 10.1242/bio.044362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Wei L, Wang B, Hu L, Xu Y, Li Z, Shen Y, Huang H. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6. Aging (Albany NY) 2020;12:21091-113. [PMID: 33188661 DOI: 10.18632/aging.103196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Qi H, Fan W. Value of ablation therapy in the treatment of lung metastases. Thorac Cancer 2018;9:199-207. [PMID: 29193688 DOI: 10.1111/1759-7714.12567] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
16 Wu ZX, Yang Y, Zeng L, Patel H, Bo L, Lin L, Chen ZS. Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line. Front Oncol 2020;10:624954. [PMID: 33692943 DOI: 10.3389/fonc.2020.624954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Liang L, Wang L, Zhu P, Xia Y, Qiao Y, Wu J, Zhuang W, Fei J, Wen Y, Jiang X. A Pilot Study of Apatinib as Third-Line Treatment in Patients With Heavily Treated Metastatic Colorectal Cancer. Clinical Colorectal Cancer 2018;17:e443-9. [DOI: 10.1016/j.clcc.2018.02.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
18 Ren Y, Li Y, Zhang W, Yang K, Li J, Hu Y, Zuo Z, Xu C, Pan Y, Zhang X. Mir-4746 inhibits the proliferation of colorectal cancer cells in vitro and in vivo by targeting CCND1. Biochemical and Biophysical Research Communications 2022;594:153-60. [DOI: 10.1016/j.bbrc.2022.01.063] [Reference Citation Analysis]
19 Harrison LE, Bleiler M, Giardina C. A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeutically. Biochem Pharmacol 2018;147:1-8. [PMID: 29128368 DOI: 10.1016/j.bcp.2017.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
20 Raquel-Cunha A, Cardoso-Carneiro D, Reis RM, Martinho O. Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling. Cells 2019;8:E442. [PMID: 31083461 DOI: 10.3390/cells8050442] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 Pak JN, Jung JH, Park JE, Hwang J, Lee HJ, Shim BS, Kim SH. p53 dependent LGR5 inhibition and caspase 3 activation are critically involved in apoptotic effect of compound K and its combination therapy potential in HCT116 cells. Phytother Res 2020;34:2745-55. [PMID: 32403193 DOI: 10.1002/ptr.6717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Liu L, Zhai Z, Wang D, Ding Y, Chen X, Wang Q, Shu Z, Wu M, Chen L, He X, Fan D, Pan F, Xing M. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis. Gene 2021;769:145187. [PMID: 32998046 DOI: 10.1016/j.gene.2020.145187] [Reference Citation Analysis]
23 Li Q, Yue W, Li M, Jiang Z, Hou Z, Liu W, Ma N, Gan W, Li Y, Zhou T, Yue W, Chen S. Downregulating Long Non-coding RNAs CTBP1-AS2 Inhibits Colorectal Cancer Development by Modulating the miR-93-5p/TGF-β/SMAD2/3 Pathway. Front Oncol 2021;11:626620. [PMID: 33937030 DOI: 10.3389/fonc.2021.626620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Zhang PF, Xie D, Li Q. Cost-effectiveness analysis of fruquintinib as third-line treatment for patients with metastatic colorectal cancer. Tumori 2020;106:400-5. [PMID: 32354261 DOI: 10.1177/0300891620916789] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Huang CC, Liu FR, Feng Q, Pan XY, Song SL, Yang JL. RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480. BMC Cancer 2021;21:321. [PMID: 33765976 DOI: 10.1186/s12885-021-08056-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wang T, Sun H, Bao Y, En R, Tian Y, Zhao W, Jia L. POM121 overexpression is related to a poor prognosis in colorectal cancer. Expert Rev Mol Diagn 2020;20:345-53. [PMID: 31858845 DOI: 10.1080/14737159.2020.1707670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
27 Xue S, Xing Y, Song HW. FTY720 inhibits colon cancer cell survival and increases their sensitivity to gemcitabine through the miR-494/MST1 pathway. Shijie Huaren Xiaohua Zazhi 2020; 28(6): 217-225 [DOI: 10.11569/wcjd.v28.i6.217] [Reference Citation Analysis]
28 Chen S, Wang B, Fu X, Liang Y, Chai X, Ye Z, Li R, He Y, Kong G, Lian J, Li X, Chen T, Zhang X, Qiu X, Tang X, Zhou K, Lin B, Zeng J. ALKAL1 gene silencing prevents colorectal cancer progression via suppressing Sonic Hedgehog (SHH) signaling pathway. J Cancer 2021;12:150-62. [PMID: 33391411 DOI: 10.7150/jca.46447] [Reference Citation Analysis]
29 Chang C, Pan T. Identification of bioactive compounds in Lactobacillus paracasei subsp. paracasei NTU 101-fermented reconstituted skimmed milk and their anti-cancer effect in combination with 5-fluorouracil on colorectal cancer cells. Food Funct 2019;10:7634-44. [DOI: 10.1039/c9fo01819k] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Kong X, Liu C, Lu P, Guo Y, Zhao C, Yang Y, Bo Z, Wang F, Peng Y, Meng J. Combination of UPLC-Q-TOF/MS and Network Pharmacology to Reveal the Mechanism of Qizhen Decoction in the Treatment of Colon Cancer. ACS Omega 2021;6:14341-60. [PMID: 34124457 DOI: 10.1021/acsomega.1c01183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
31 Petroni G, Bagni G, Iorio J, Duranti C, Lottini T, Stefanini M, Kragol G, Becchetti A, Arcangeli A. Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K. Cell Death Dis 2020;11:161. [PMID: 32123164 DOI: 10.1038/s41419-020-2349-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
32 Mammes A, Pasquier J, Mammes O, Conti M, Douard R, Loric S. Extracellular vesicles: General features and usefulness in diagnosis and therapeutic management of colorectal cancer. World J Gastrointest Oncol 2021; 13(11): 1561-1598 [PMID: 34853637 DOI: 10.4251/wjgo.v13.i11.1561] [Reference Citation Analysis]
33 van Rosmalen M, Ni Y, Vervoort DFM, Arts R, Ludwig SKJ, Merkx M. Dual-Color Bioluminescent Sensor Proteins for Therapeutic Drug Monitoring of Antitumor Antibodies. Anal Chem 2018;90:3592-9. [PMID: 29443503 DOI: 10.1021/acs.analchem.8b00041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
34 Luo W, Liu Q, Chen X, Liu H, Quan B, Lu J, Zhang K, Wang X. FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer. Biomed Res Int 2021;2021:9986376. [PMID: 34212047 DOI: 10.1155/2021/9986376] [Reference Citation Analysis]
35 Gu Y, Huang Y, Sun Y, Liang X, Kong L, Liu Z, Wang L. [Long non-coding RNA LINC01106 regulates colorectal cancer cell proliferation and apoptosis through the STAT3 pathway]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1259-64. [PMID: 32990221 DOI: 10.12122/j.issn.1673-4254.2020.09.06] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Adams J, Casali A, Campbell K. Sensitive High-Throughput Assays for Tumour Burden Reveal the Response of a Drosophila melanogaster Model of Colorectal Cancer to Standard Chemotherapies. Int J Mol Sci 2021;22:5101. [PMID: 34065887 DOI: 10.3390/ijms22105101] [Reference Citation Analysis]
37 Sanchez JN, Wang T, Cohen MS. BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers. Drugs 2018;78:549-66. [PMID: 29488071 DOI: 10.1007/s40265-018-0884-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 14.7] [Reference Citation Analysis]
38 Shi H, Tian S, Tian H. Network Pharmacology Interpretation of Fuzheng-Jiedu Decoction against Colorectal Cancer. Evid Based Complement Alternat Med 2021;2021:4652492. [PMID: 33688358 DOI: 10.1155/2021/4652492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Li J, Guo C, Lu X, Tan W. Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks. European Journal of Pharmacology 2019;858:172483. [DOI: 10.1016/j.ejphar.2019.172483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
40 Li H, Zhang N, Jiao X, Wang C, Sun W, He Y, Ren G, Huang S, Li M, Chang Y, Jin Z, Xie Q, Zhang X, Huang H, Jin H. Downregulation of microRNA-6125 promotes colorectal cancer growth through YTHDF2-dependent recognition of N6-methyladenosine-modified GSK3β. Clin Transl Med 2021;11:e602. [PMID: 34709763 DOI: 10.1002/ctm2.602] [Reference Citation Analysis]
41 Wu W, Chen Y, Ye S, Yang H, Yang J, Quan J. Transcription factor forkhead box K1 regulates miR-32 expression and enhances cell proliferation in colorectal cancer. Oncol Lett 2021;21:407. [PMID: 33841568 DOI: 10.3892/ol.2021.12668] [Reference Citation Analysis]
42 Zhuang QS, Sun XB, Chong QY, Banerjee A, Zhang M, Wu ZS, Zhu T, Pandey V, Lobie PE. ARTEMIN Promotes Oncogenicity and Resistance to 5-Fluorouracil in Colorectal Carcinoma by p44/42 MAPK Dependent Expression of CDH2. Front Oncol 2021;11:712348. [PMID: 34422665 DOI: 10.3389/fonc.2021.712348] [Reference Citation Analysis]
43 Feng Q, Xu D, Zhou M, Wu Z, Wu Z, Wang Z, Bi J, Pei W. CDC42EP3 promotes colorectal cancer through regulating cell proliferation, cell apoptosis and cell migration. Cancer Cell Int 2021;21:169. [PMID: 33726765 DOI: 10.1186/s12935-021-01845-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Galán-Martínez J, Stamatakis K, Sánchez-Gómez I, Vázquez-Cuesta S, Gironés N, Fresno M. Isoform-specific effects of transcription factor TCFL5 on the pluripotency-related genes SOX2 and KLF4 in colorectal cancer development. Mol Oncol 2021. [PMID: 34623757 DOI: 10.1002/1878-0261.13085] [Reference Citation Analysis]
45 Moioli M, Barra F, Maramai M, Valenzano Menada M, Vellone VG, Costantini S, Ferrero S. Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs. Expert Opinion on Investigational Drugs 2019;28:1025-9. [DOI: 10.1080/13543784.2019.1693999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
46 Ju M, Cheng H, Qu K, Lu X. Efficacy and safety of ramucirumab treatment in patients with advanced colorectal cancer: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e20618. [PMID: 32541497 DOI: 10.1097/MD.0000000000020618] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Yang T, Wang H, Li M, Yang L, Han Y, Liu C, Zhang B, Wu M, Wang G, Zhang Z, Zhang W, Huang J, Zhang H, Cao T, Chen P, Zhang W. CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1. Int J Biol Sci 2021;17:848-60. [PMID: 33767593 DOI: 10.7150/ijbs.53657] [Reference Citation Analysis]
48 Liu N, Wu C, Jia R, Cai G, Wang Y, Zhou L, Ji Q, Sui H, Zeng P, Xiao H, Liu H, Huo J, Feng Y, Deng W, Li Q. Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Front Pharmacol 2020;11:478. [PMID: 32372960 DOI: 10.3389/fphar.2020.00478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Xiong G, Zhang J, Zhang Y, Pang X, Wang B, Zhang Y. Circular RNA_0074027 participates in cell proliferation, apoptosis and metastasis of colorectal cancer cells through regulation of miR‑525‑3p. Mol Med Rep 2021;23:324. [PMID: 33760126 DOI: 10.3892/mmr.2021.11963] [Reference Citation Analysis]
50 Duan L, Yang W, Feng W, Cao L, Wang X, Niu L, Li Y, Zhou W, Zhang Y, Liu J, Zhang H, Zhao Q, Hong L, Fan D. Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer. Ther Adv Med Oncol 2020;12:1758835920947342. [PMID: 32922521 DOI: 10.1177/1758835920947342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
51 Nguyen BT, Pyun JC, Lee SG, Kang MJ. Identification of new binding proteins of focal adhesion kinase using immunoprecipitation and mass spectrometry. Sci Rep 2019;9:12908. [PMID: 31501460 DOI: 10.1038/s41598-019-49145-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Li X, Yuan D, Liu Y, Zhu L, Qin H, Yang Y, Li Y, Yan F, Wang Y. Panax notoginseng saponins prevent colitis-associated colorectal cancer via inhibition IDO1 mediated immune regulation. Chinese Journal of Natural Medicines 2022;20:258-69. [DOI: 10.1016/s1875-5364(22)60179-1] [Reference Citation Analysis]
53 Muro K, Salinardi T, Singh AR, Macarulla T. Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data. Cancers (Basel) 2020;12:E844. [PMID: 32244546 DOI: 10.3390/cancers12040844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Balhorn R, Balhorn MC, Balakrishnan K, Rebhun RB. The small molecule antibody mimic SH7139 targets a family of HLA-DRs expressed by B-cell lymphomas and other solid cancers. J Drug Target 2020;28:1124-36. [PMID: 32588667 DOI: 10.1080/1061186X.2020.1787418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Li W, Guo J, Wang Q, Tang J, You F. The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: A protocol for systematic review of randomized controlled trials. Medicine (Baltimore) 2020;99:e23216. [PMID: 33371062 DOI: 10.1097/MD.0000000000023216] [Reference Citation Analysis]
56 Xiong B, Xie Z, Song F, Chen H, Wang X, Jin Z, Han T, Li Y, Zhang D. DDR1 promotes LoVo cell proliferation by regulating energy metabolism. Acta Biochim Biophys Sin (Shanghai) 2022. [PMID: 35593476 DOI: 10.3724/abbs.2022038] [Reference Citation Analysis]
57 Zhang X, Yang Y, Zhang W, Huang K, Xu L, Shahid N, Pan Y, Xu C, Jiao X, Yang K. Downregulation of MiR-1538 promotes proliferation and metastasis of colorectal cancer by targeting DNMT3A. Biochemical and Biophysical Research Communications 2022;609:119-26. [DOI: 10.1016/j.bbrc.2022.04.006] [Reference Citation Analysis]